The Role of IL-17 in Patients with Respiratory Syncytial Virus (RSV) Causing Upper and Lower Respiratory Tract Infections

Venus  Hassan Abdul Amir

Venus Hassan Abdul Amir College of science, Al-Qasim Green university, Iraq

Keywords: RSV, IgG, ELISA, IL-17

Abstract

Search of IgG from 100 patients with URTI and LRTI were diagnosed as RSV in ELISA test. The lower proportions of severe/critical cases werenoted at the lowest within-age group range (5 years), which show a
significant difference between age groups. The notable sex-differencewas where distilled water infected more females than males. Therewas little change in upper versus lower respiratory tract infection rates
and urban versus rural infection rates. In the same way, there was nosignificant difference between IL17 levels in infected and uninfected people.

DOI: https://doi.org/10.24321/0019.5138.202674

How to cite this article:
Amir V H A. The Role of Il-17 in Patients with Respiratory Syncytial Virus (Rsv) Causing Upper
and Lower Respiratory Tract Infections. J CommunDis. 2026;58(3): 158-161.

References

Centers for Disease Control and Prevention. RSV

in adults. https://www.cdc.gov/rsv/older-adults/.

Accessed 4 January 2024. https://www.cdc.gov/

rsv/adults/index.html

Suryadevara M, Domachowske JB. Epidemiology

and seasonality of childhood respiratory syncytial

virus infections in the tropics. Viruses 2021; 13:696.

[Google Scholar] [PubMed]

Shi T, Denouel A, Tietjen AK, et al. Global disease

burden estimates of respiratory syncytial virus-

associated acute respiratory infection in older

adults in 2015: a systematic review and meta-

analysis. J Infect Dis 2020; 222:S577–83. [Google

Scholar] [PubMed]

Branche AR, Saiman L, Walsh EE, et al. Incidence

of respiratory syncytial virus infection among

hospitalized adults, 2017–2020. Clin Infect Dis

; 74:1004–11. [Google Scholar] [PubMed]

European Medicines Agency. First vaccine to

protect older adults from respiratory syncytial

virus (RSV) infection. https://www.ema.europa.

eu/en/news/first-vaccine-protect-older-adults-

respiratory-syncytial-virus-rsv-infection. Accessed

May 2023https://www.ema.europa.eu/

en/news/first-vaccine-protect-older-adults-

respiratory-syncytial-virus-rsv-infection. Accessed

May 2023